Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fangjing Hong"'
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are due to the active components, which may lead to step-up
Externí odkaz:
https://doaj.org/article/685728c123b74d248adf2a7bf5e1f3bf
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Gastroenterology
BMC Gastroenterology
Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are due to the active components, which may lead to step-up treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e7910e491e860244afeee2a5b1b245
http://link.springer.com/article/10.1186/s12876-019-1049-2
http://link.springer.com/article/10.1186/s12876-019-1049-2